Profound Medical Corp. announced that it has successfully completed the first sale of a TULSA-PRO system in Finland to the Turku University Hospital (“Tyks”). The deal was completed in collaboration with Philips, who is working in partnership with Profound to commercialize the TULSA-PRO system in Europe.

Samsung NeuroLogica announced that its portable computed tomography (CT) technology will be included in Carolinas HealthCare System’s Levine Cancer Institute’s innovative Mobile Lung CT Unit. The unit will bring lung cancer diagnosis and intervention to underserved populations in the Carolinas.

March 21, 2017 — Toshiba Medical demonstrated its Forward projected model-based Iterative Reconstruction SoluTion (FIRST ...

EchoPixel recently announced progress in the clinical adoption of its True 3D virtual reality software in pediatric surgical procedures. At several leading clinical sites, the company said surgeons and radiologists are adopting True 3D powered by HP to develop surgical plans, effectively communicate in a common 3-D language, and assist in challenging procedures - including a 17-hour operation to separate conjoined twins.

Patients in their 80s and 90s who have early-stage lung cancer but cannot undergo an operation can be treated safely and effectively with stereotactic body radiation therapy (SBRT), according to research presented at the 2017 Multidisciplinary Thoracic Cancers Symposium. The advanced form of radiation therapy (RT) was well tolerated among this relatively understudied elderly population, indicating that SBRT is a viable option for patients who may otherwise be offered no curative treatment.

March 16, 2017 — Exact Imaging has received Health Canada approval and the corresponding medical device license (#98667) ...

Solis Mammography recently released a statement taking issue with incorrectly interpreted terminology used by reporters and others referring to a mammogram callback as a “false positive.” As evidence, the statement highlighted a study published Feb. 9 in the journal Cancer Epidemiology, Biomarkers & Prevention that referred to mammography recalls as false positive mammograms. This led to news reports across the country stating that a false positive was defined as “a doctor telling a woman that cancer is present, but it turns out not to be.” Solis Mammography said this is more than a simple misspeak on the part of a reporter. It’s a common misunderstanding and is blatantly false.

During the 66th Annual Scientific Session & Expo of the American College of Cardiology (ACC), March 17-19 in Washington, D.C., Siemens Healthineers will showcase technologies that integrate images and information at every step of the treatment process, with a theme of “Making Complex Simple.”

Researchers at the University of California Irvine now have access to Toshiba Medical’s most advanced magnetic resonance (MR) technology for their cutting-edge neurology work investigating cerebral microbleeds (CMB) in high school football players as a potential precursor to chronic traumatic encephalopathy (CTE). As part of its ongoing, first-of-its-kind study to identify early signs of brain trauma in young athletes, UCI doctors will now leverage Toshiba Medical’s Vantage Galan 3T MR system as a key diagnostic tool.